Assessment of Updated Evaluation Scores in Critically ILL COPD Patients Admitted to Assiut University Hospital
NCT ID: NCT02259439
Last Updated: 2015-04-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2012-09-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Rational of the study:to identify the predictive factors for hospital mortality in critically ill patients admitted to hospital due to an episode of COPD exacerbation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of Bronchiectasis in COPD Patients
NCT04101448
Predictors of Hospital Readmission for Chronic Obstructive Pulmonary Disease Patients
NCT06348966
nCD64 vs. Neutrophil/Lymphocyte Ratio for Predicting In-hospital Outcome in AE-COPD
NCT03146611
Performance of Novel Bed Side Scores as Predictors of Hospital Outcome in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Among Women; Cohort Study
NCT05370664
Retrospective Evaluation of COPD Patient Care
NCT02433223
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A) sociodemographic variables:
Age, sex, marital status, occupation, pack\\year.
B) clinical variables:
1- Dyspnea measured by the Medical Research Council (MRC) scale and the COPD Assessment Test (CAT ) while stable, previous to admittance.
3- Charlson comorbidity index and age adjusted model.
4- The APACHE II scale: the severity of the episode upon admittance, calculated using the APACHE II scale, using the worst value obtained in the first 24h after being admitted to hospital.
5- the Sequential Organ Failure Assessment (SOFA) scale.
6- Lab parameters: such as glucose, albumin and heamatocrit
7- BAP-65 score: elevated blood urea nitrogen, altered mental status, pulse \> 109 beats/min, age \> 65 years.
8- Assessment of symptom of gastroesophageal reflux disease.
9-Glasgow scale score.
10-CURB 65 :"C" stands for "confused"; "U" stands for BUN greater than19 mg/dL; "R" stands for "respiration more than 30 breaths per minute""B" stands for blood pressure less than 90 mm Hg systolic or diastolic blood pressure 60 mm Hg or less; "65" stands ≥65 years.
11-CAUDA 70: C: Confusion, Acidosis (pH \<7.35), Urea \>7mmol/L, MRC Dyspnoea score \>4, Albumin \<35g/L, Age \>70 years. One point was assigned to each variable present, giving a six point scoring system.
12-The COPD and Asthma Physiology Score.
13-The early warning score.
14-ADO index: comprised of age, dyspnea by the MRC, and FEV1. Scores ranged from 0 (best status) to 5 (worst status) for age, 0-3 for MRC, and 0-2 for FEV1. Points for each component were added so that the ADO index ranged from 0 to 10.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Specific diagnosis: pulmonary edema, rib fractures, aspiration, pleural effusion, etc. upon admission.
* Other associated respiratory pathology that determines treatment: pulmonary fibrosis, kyphoscoliosis, neuromuscular pathology, upper airway obstruction, extensive tuberculosis sequelae.
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nermeen Aly Mahmoud Abdel Aleem
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nermeen Aly Mahmoud Abdel Aleem
chest department- faculity of medicine -Assiut university- Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chest Department-faculty of medicine-Assuit university
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16022012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.